22 August 2018
Visiongain’s new report Global Medical Device Contract Manufacturing Market : Electronic Manufacturing Services, Materials Processing, Finished Products, Medical Diagnostic Devices, Monitoring & Surgical Equipments, Therapeutic Devices indicates that the global medical device contract manufacturing market will see $102.9bn in spending in 2021.
The lead analyst of the report said: ““The global market for medical device contract manufacturing in 2016 was valued at $63.0bn. Outsourcing of various processes in the medical device development cycle is now seen as an essential strategy by OEMs to ensure return on investment. The medical device contract manufacturing market is highly fragmented, with several thousand companies providing a range of services from machining, moulding, stamping, assembly, to packaging. The industry has many small organisations generating revenue of less than $5m annually. These organisations tend to be specialists in one technology. There are also several large CMOs generating revenues of over $100m. The medical device contract manufacturing industry has witnessed consolidation and increasing business from the OEMs. Although there are still many small companies with less than $5m in revenues, the industry is expected to witness more consolidation in the near future, visiongain believes.”
The 247-page report contains 75 tables and 95 figures that add visual analysis in order to explain developing trends within the Global Medical Device Contract Manufacturing market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Electronic Manufacturing Services, Materials Processing and Finished Products.
The 247-page report offers market forecasts and analysis for the leading medical device contact manufacturing national markets: the US, Japan, EU5 (the UK, Germany, France, Spain, and Italy), China, Central America & South America, India and Rest of the World
In addition, the report contains a dedicated leading companies’ chapter covering the leading companies in the medical device contract manufacturing market:
The Global Medical Device Contract Manufacturing Market Forecast 2017-2027: Electronic Manufacturing Services, Materials Processing, Finished Products, Medical Diagnostic Devices, Monitoring & Surgical Equipments, Therapeutic Devices report will be of value to anyone who wants to better understand the medical device contract manufacturing market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the medical device contract manufacturing industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global Pharma Wholesale and Distribution market is estimated at US$844.2 billion in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.
20 February 2024
The global Biobanking market is estimated at US$75.4 billion in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period 2024-2034.
19 February 2024
The Dermatological Drugs market is estimated at US$30.47 billion in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period 2024-2034.
13 February 2024
The global Allergic Rhinitis Drugs market is estimated at US$16,821.6 million in 2024 and is expected to register a CAGR of 2.7% from 2024 to 2034.